GPT and hemophilia: Hemophilia GT was full of exceptions since the vector differed from other diseases discussed, for example, in hemophilia gene therapy trials, patients were treated in different cohorts with varying doses of the gene therapy material, unlike other approaches for different diseases and the only common AE evident was the elevated ALT level.